Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
1960
Clinical Trial Start Date
2011
0Primary Completion Date
2012
0Study Completion Date
2012
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Intervention Name
ACT-2807780
Amlodipine0
Placebo0
Interventional Trial Phase
Phase 20
Official Name
A Multi-center, Double-blind, Randomized, Placebo- and Active-controlled, Parallel-group, Proof-of-concept Study to Evaluate the Efficacy, Safety, and Tolerability of 10 mg of ACT-280778 in Patients With Mild to Moderate Essential Hypertension0
Last Updated
September 27, 2018
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Quadruple0
Masked Party
Participant0
Outcomes Assessor0
Investigator0
Care Provider0
Study summary
The purpose of this study is to demonstrate the antihypertensive efficacy of once daily oral administration of ACT 280778 on DBP compared to placebo after 28 days.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
